EDESA BIOTECH, INC. Operating Lease, Expense
EDESA BIOTECH, INC. (EDSA) reported Operating Lease, Expense of $38.57 thousand for the 6-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-05-15
- EDESA BIOTECH, INC. operating lease, expense for the quarter ending 2020-03-31 was $19.13K.
- EDESA BIOTECH, INC. operating lease, expense for the quarter ending 2019-12-31 was $19.44K.
- EDESA BIOTECH, INC. operating lease, expense for the quarter ending 2019-03-31 was $0.00.
- EDESA BIOTECH, INC. operating lease, expense for the quarter ending 2018-12-31 was $0.00.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month |
|---|---|---|
| 2020-03-31 | $19.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | $38.57K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $19.44K 10-Q · filed 2020-02-13 | |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | $0.00 10-Q · filed 2020-05-15 |
| 2018-12-31 | $0.00 10-Q · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |